-
公开(公告)号:US20200283466A1
公开(公告)日:2020-09-10
申请号:US16878911
申请日:2020-05-20
Applicant: Hayashibara Co. Ltd.
Inventor: Mitsuyuki KAMBE , Koichi NISHI , Akira KAWASHIMA , Akiko YASUDA , Hitoshi MITSUZUMI , Toshio ARIYASU
IPC: C07H17/07 , A61Q19/00 , A61K31/7048 , A23L27/00 , A23L27/20 , A23L33/10 , A23L33/15 , A61K8/60 , C12P19/60 , A23L2/52 , C12P19/18 , C12P19/14
Abstract: The present invention aims to provide a novel glycosyl hesperetin, which is significantly reduced in miscellaneous tastes characteristic of conventional products containing glycosyl hesperetin, and a method for producing the same and uses thereof; and the objects are solved by providing a glycosyl hesperetin which comprises glycosyl hesperetin in an amount of 90% or more by mass but less than 100% by mass, on a dry solid basis, but it does not substantially contain furfural, and a method for producing the same and uses thereof.
-
公开(公告)号:US20180243195A1
公开(公告)日:2018-08-30
申请号:US15756698
申请日:2016-09-01
Applicant: Hayashibara Co., Ltd.
Inventor: Masaki MIYAKE , Motoyuki SUZUKI , Tatsuya ISHIHARA , Toshio ARIYASU
CPC classification number: A61K8/602 , A61K8/36 , A61K8/365 , A61K8/368 , A61K8/49 , A61K8/498 , A61K8/60 , A61K9/08 , A61K9/16 , A61K9/20 , A61K31/19 , A61K31/198 , A61K31/353 , A61K31/702 , A61K31/7048 , A61Q19/00 , A61Q19/02
Abstract: [Object] The present invention has an object to provide an external dermal agent for reducing skin yellowness already generated in the skin.[Means to Attain the Object] The above object is solved by providing an external dermal agent for reducing skin yellowness already generated in the skin, which contains hesperetin and/or glycosyl hesperetin as an effective ingredient(s).
-
公开(公告)号:US20170081354A1
公开(公告)日:2017-03-23
申请号:US15122708
申请日:2015-03-03
Applicant: Hayashibara Co. Ltd.
Inventor: Mitsuyuki KAMBE , Koichi NISHI , Akira KAWASHIMA , Akiko YASUDA , Hitoshi MITSUZUMI , Toshio ARIYASU
IPC: C07H17/07 , A61K8/60 , A61Q19/00 , A23L33/15 , C12P19/60 , A23L27/20 , A23L27/00 , A23L33/10 , A61K31/7048 , C12P19/14
Abstract: The present invention aims to provide a novel glycosyl hesperetin, which is significantly reduced in miscellaneous tastes characteristic of conventional products containing glycosyl hesperetin, and a method for producing the same and uses thereof; and the objects are solved by providing a glycosyl hesperetin which comprises glycosyl hesperetin in an amount of 90% or more by mass but less than 100% by mass, on a dry solid basis, but it does not substantially contain furfural, and a method for producing the same and uses thereof.
-
公开(公告)号:US20220031690A1
公开(公告)日:2022-02-03
申请号:US17279760
申请日:2019-09-24
Applicant: Hayashibara Co., Ltd.
Inventor: Hitomi OHTA , Satomi MIYATA , Takashi MORIMOTO , Akira HARASHIMA , Toshio ARIYASU
IPC: A61K31/4709
Abstract: The present invention addresses the problem of providing an orally-administrable anti-neurodegenerative disease agent having an action of accelerating neurocyte growth and an action of promoting neurite-outgrowth, and having excellent transfer properties to central nervous tissues. The problem is solved by providing an anti-neurodegenerative disease agent containing a compound represented by General formula 4 as an active ingredient, and having an action of accelerating neurocyte growth, an action of promoting neurite-outgrowth, and an action of scavenging reactive oxygen species. In General formula 4, R10 and R11 represent the same or different alkyl group having 2-8 carbon atoms, and the alkyl group may be either a straight chain or a branched chain. n represents an integer of 0 or 1, and X4− represents a suitable counter anion that is pharmaceutically acceptable.
-
公开(公告)号:US20210161791A1
公开(公告)日:2021-06-03
申请号:US16071137
申请日:2017-01-19
Applicant: Hayashibara Co., Ltd.
Inventor: Masaki KONO , Masahiro FUJIMOTO , Yutaka AKAGI , Akiko MIYAKE , Toshio ARIYASU
Abstract: An object of the present invention is to provide a particulate composition containing crystalline α,α-trehalose dihydrate, having an advantageous emulsifying ability.
The above object is solved by providing a particulate composition comprising crystalline α,α-trehalose dihydrate, which consists of particles containing α,α-trehalose and maltose and/or maltotriose, wherein said particulate composition contains α,α-trehalose in an amount of 70% by weight or higher but 90% by weight or lower, on a dry solid basis; and maltose and/or maltotriose in a total amount of 3% by weight or higher, on a dry solid basis; and has a degree of crystallinity for crystalline α,α-trehalose dihydrate of 25% or higher but less than 90%, when calculated based on its powder X-ray diffraction profile.
-
-
-
-